This CTD dossier owner and manufacturer is a pharmaceutical manufacturer with a strong commitment to quality and safety. Their products include solid dosage forms like tablets, capsules, sachets, and dry powder suspensions. They focus on research and development, utilizing cutting-edge technologies to meet international standards. The company holds cGMP certifications from the Pharmaceutical Inspection Convention (PIC/s) and has a dedicated team of researchers and regulatory experts. While they operate globally with a presence in diverse regions like the EU and North America, specific therapy areas and product patents are not mentioned.
Manufacturer usually replies in 26 days
Tiotropium Bromide, also known by its popular brand name of Spiriva, is a long-acting bronchodilator medication used in the management of chronic obstructive pulmonary disease and asthma. Specifically, this drug is produced by manufacturers to proactively prevent periods of worsening rather than for those periods themselves. Tiotropium Bromide was originally patented in 1989 by a pharmaceutical products company and was subsequently submitted and gained regulatory approval for sale on the medical marketplace in 2002.
Currently, it is on the World Health Organization's List of Essential Medicines, indicating that it is a cost-efficient and effective medicine recommended for use in health systems across the globe. As such, it has become extremely popular, being the 82nd most commonly prescribed medication in the United States in 2017 with more than 9 million prescriptions. However, as of 2019, there is no generic version available in the United States, limiting the proliferation of Tiotropium Bromide manufacturers and Tiotropium Bromide suppliers. Regardless, Tiotropium Bromide is still frequently found available to order on the pharmaceutical products list of distributors across the global marketplace, where it can be found for sale and wholesale at a variety of cost and price points.
Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence.